Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial

Abstract

Tiotropium <i>via</i> HandiHaler over 6 months significantly improved lung function but not frequency of exacerbations. Further research is required to understand the clinical context and significance of these findings.